NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo a dramatic transformation. From the spire of One World Trade Center in Manhattan to the mist-covered precipice of Niagara Falls, more than 325 iconic landmarks across 50 U.S. states and 20 countries will be bathed in a specific triad of colors: teal, green, and pink.
This coordinated display marks the tenth year of a burgeoning movement dedicated to National Metastatic Breast Cancer (MBC) Awareness Day. Organized by METAvivor Research and Support, the #LightUpMBC campaign seeks to rectify a long-standing grievance within the oncology community: the relative invisibility of Stage 4 patients during Breast Cancer Awareness Month. While October is traditionally dominated by "pink ribbon" messaging focused on early detection and "survivorship" milestones, #LightUpMBC shines a light on the 100% of breast cancer deaths that result from metastatic disease—a condition for which there is currently no cure.
Main Facts: A Global Call to Action for Stage 4 Research
The 2026 campaign represents the largest iteration of #LightUpMBC to date. The scale of the event—spanning 195 cities worldwide—underscores a growing international demand for research funding that specifically targets late-stage disease. Unlike early-stage breast cancer, which is often treated with a finite regimen of surgery, radiation, and chemotherapy, metastatic breast cancer requires lifelong, continuous treatment.
Metastatic breast cancer occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to settle in distant organs. The most common sites of metastasis are the bones, liver, lungs, and brain. Despite common misconceptions, even if the cancer is found in the brain, it remains breast cancer and is treated with protocols designed for breast malignancies.
The #LightUpMBC campaign serves three primary functions:
- Visibility: Utilizing landmarks like the Willis Tower in Chicago and the Mactan-Cebu Airport in the Philippines to force a public conversation about the realities of Stage 4.
- Education: Dispelling the myth that "early detection saves all lives," as roughly 30% of women diagnosed with early-stage breast cancer will eventually progress to metastatic disease, sometimes decades later.
- Fundraising: 100% of the net proceeds from the campaign and its associated live stream are funneled directly into scientific grants for MBC research.
Chronology: From a Single Bridge to a Global Phenomenon
The history of #LightUpMBC is a testament to the power of grassroots patient advocacy. The campaign was born from the vision of Jessica Moore, a young woman diagnosed with MBC who recognized the stark disconnect between the "pink" celebration of October and the terminal reality of her diagnosis.
In 2017, Moore’s hope was to see just one local landmark illuminated to represent the MBC community. That year, the Memorial Bridge in Portsmouth, New Hampshire, became the first structure to glow in the MBC colors. Tragically, Moore passed away at the age of 36, but her legacy sparked a firestorm of advocacy.
Under the leadership of campaign founder Laura Inahara and METAvivor, the initiative grew exponentially:
- 2017–2019: The movement spread across the Northeastern United States, gaining traction through social media and local patient networks.
- 2020: Despite the global pandemic, the campaign pivoted to a digital-first strategy, launching #LightUpMBC Live, a virtual broadcast that allowed patients to participate from their homes.
- 2021–2025: The campaign achieved "All 50 States" status and began its international expansion, securing landmarks in the United Kingdom, Canada, and Southeast Asia.
- 2026: The current year marks a milestone of 325+ landmarks, having raised over $2.7 million for research since its inception.
Supporting Data: The Stark Reality of the 2026 Oncology Landscape
The necessity of the #LightUpMBC campaign is backed by sobering epidemiological data. According to the Surveillance, Epidemiology, and End Results (SEER) program, an estimated 42,670 people in the United States are expected to die from breast cancer in 2026. This equates to approximately 117 deaths every single day.
The Funding Disparity
Historically, metastatic research has been underfunded. Advocacy groups point out that while billions are raised for breast cancer annually, only an estimated 7% to 10% of those funds are typically directed toward research for stage 4 disease. METAvivor was founded specifically to bridge this gap, ensuring that 100% of its research grants are dedicated to the metastatic stage.
The Biological Challenge
MBC is not a monolith. Patients may be diagnosed "de novo" (at Stage 4 from the start) or experience a recurrence years after being told they were "cancer-free." The 2026 data highlights that while modern therapies—such as CDK4/6 inhibitors, antibody-drug conjugates (ADCs), and immunotherapy—have extended the median survival rate, the disease eventually develops resistance.
"Treatment for MBC is a game of musical chairs," explains one oncology researcher. "You stay on one drug until the cancer figures out a way around it, then you move to the next. The goal of METAvivor is to ensure that the ‘chairs’ never run out."
Official Responses: Voices from the Frontlines
The 2026 campaign features a diverse array of voices from the medical, advocacy, and entertainment sectors.
Dr. Kelly Shanahan, METAvivor Board President, who has lived with MBC since 2013, emphasized the life-saving nature of the campaign’s funds. "When I was diagnosed, I certainly didn’t think I’d still be here 13 years later," Shanahan stated. "My hope, and the hope of so many others, lies in research. METAvivor-funded research is increasingly important because it focuses on the biology of why cancer spreads and how to stop it. #LightUpMBC is the biggest contributor to this effort."
Laura Inahara, Founder of #LightUpMBC, reflected on the emotional weight of the campaign’s growth. "Jessica Moore wanted to illuminate one landmark. Today, her legacy helps families around the world shine a light for the people they love. We are teaching patients how to advocate for themselves while raising millions for the science that will ultimately save them."
The 2026 live stream, #LightUpMBC Live, will be hosted by Tami Eagle Bowling, a survivor living with MBC for 11 years, and Broadway’s Kara Lindsay. The program is designed to blend scientific rigor with the emotional resonance of the arts. "We aren’t just showing lights on buildings," Bowling said. "We are telling the stories of the people behind those lights. We are bringing together Tony Award winners and world-class scientists to say that the MBC community will no longer be ignored."
Implications: Shifting the Paradigm from Terminal to Chronic
The broader implications of the #LightUpMBC movement extend beyond a single night of illumination. The campaign is driving a paradigm shift in how society perceives and treats metastatic disease.
1. Therapeutic Evolution
By funding Stage 4-specific research, METAvivor is accelerating the transition of MBC from a terminal diagnosis to a manageable chronic condition. In 2026, more patients are living five, ten, or even fifteen years post-diagnosis than ever before. However, the quality of life remains a critical concern, as cumulative toxicity from treatments can be debilitating. The 2026 research grants focus heavily on "precision dosing" and therapies that target cancer cells while sparing healthy tissue.
2. The Psychology of Advocacy
For patients, the #LightUpMBC campaign offers a sense of agency in a situation where they often feel powerless. The "teal, green, and pink" branding provides a distinct identity separate from the "survivor" narrative that can often feel exclusionary to those in permanent treatment.
3. Corporate and Civic Responsibility
The participation of landmarks like Philadelphia City Hall and the Ness Bridge in Scotland indicates a shift in civic awareness. Large-scale public participation forces corporations and municipal governments to acknowledge the specific needs of the metastatic community, potentially leading to better workplace protections and healthcare policies for those with chronic terminal illnesses.
Conclusion: How to Participate
The public is encouraged to join the movement on the evening of October 13. At 8 p.m. ET / 5 p.m. PT, the #LightUpMBC Live broadcast will air across the METAvivor YouTube and Facebook channels, as well as via LiveOne.
For those near participating cities, the campaign organizers request that supporters photograph the illuminated landmarks and share them on social media using the hashtags #LightUpMBC and #METAvivor.
As the 325+ landmarks glow across the globe, they serve as a silent but powerful vigil for the 117 people lost every day and a beacon of hope for the hundreds of thousands still fighting. In the words of the campaign’s organizers, the goal is simple: to keep the lights on until a cure is found.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) nonprofit organization. It is the only U.S. organization that dedicated 100% of its net annual fundraised income to metastatic breast cancer research.
Media Contact:
Tami Eagle Bowling
[email protected]
For a full list of participating landmarks and to view the livestream, visit www.lightupmbc.org.
About the Author
